logo confrence berlin


Thursday, 23 October

15.00 - 15.30
Keynote speech

Hepatitis C and Drug Use - turn the page -
Dr. med. Jörg Gölz, Berlin
16.00 - 17.00
3 national examples of hepatitis policies: Policy-maker -
drug user representative




  • Dr. Ingo Michels, Head of Unit, Office of the Federal Drug Commissioner
  • Dirk Schäffer, European Network of People Who Use Drugs, Deutsche Aids Hilfe

17.00 - 18.30
What do we want for the future: Presenting the Manifesto / Berlin Declaration:

7 stakeholders for the 7 key messages for a better hepatitis C policy and practice:

  1. Scale Up Harm Reduction Community Based Programmes - Maria Phelan, Harm Reduction International (HRI)
  2. Access to HCV Testing, Treatment and Care Services - Prof. Mojca Maticic, Clinic for Infectious Diseases and Febrile Illnesses University Medical Centre Ljubljana
  3. Access to Affordable HCV Treatments - Anya Sarang, Andrey Rylkov Foundation, Moscow
  4. Decriminalisation of People Who Use Drugs - Christopher Hallam, International Drug Policy Consortium
  5. Meaningful Involvement of High Risk Communities - Efi Kokkini, European Network of People Who Use Drugs
  6. Improved HCV and Health Literacy - Magdalena Harris, PHD, Centre of Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine
  7. Effective Targeted HCV Strategies and Action Plans - Achim Kautz, European Liver Patient Association (ELPA)  
Friday, 24 October

09.00 - 10.30

Access to hepatitis C treatment in Europe and abroad - the politics on pricing

11.00 - 12.30

Parallel Session 1: HCV treatment and care - the way forward

Parallel Session 2: HCV in migrants and MSM - challenges and responses

Parallel Session 3: HCV in prison settings

Workshop W1 Demonstration of FibroScan® testing

  • Dr. Elisabeth Avril, Assoc. Gaia, Paris

Workshop W2 How to create impact on policy making for HCV?

  • Jose Queiroz, Apdes



Parallel Session 1: Hepatitis C testing and treatment barriers among active drug users

Parallel Session 2: Drug User Driven Session

  • Miguel Velazquez Gorsse - ASUD’s experience: 20 years of peer-to- peer-work to become aware of Hep C
  • Maria Teresa Ninni - HCV Peer Support: the alliance between practical experien ces and professional knowledge
  • The Swedish Drug User Union: Liver or die! 

Parallel Session 3: Hep C policy between negligence and adaption: Ukraine, Russia and European Union

Parallel Session 4: Reach out to patient groups - what works and what not

Workshop: W3

  • HCV prevention skills Trainer: Danny Morris, Andrew Preston
  • Topics to be addressed: strate- gies to reduce accidental sha- ring; the role of foil provision; increasing NPS coverage
 16.00 - 17.00  The future of HCV treatment and policy: what‘s next